A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and safety of KRX-0502, administered
without food, in treating iron deficiency anemia in subjects with stage 3 to 5 non-dialysis
dependent chronic kidney disease (NDD-CKD).